Trending now
Lions beat steep odds to capture Korean…
Cosm rides premium moviegoing wave with more…
Lions to start homegrown ace in bid…
Soult Introduces the World’s First Secure Digital…
Where’s the growth? Legacy automakers face a…
Small retailers brace for ‘huge hit’ this…
Wiz lose 2 regulars to injuries in…
Marc Lore’s Wonder confidentially files for IPO
Australia’s Property Market Has Changed: SMD Property…
Euro Stablecoins Added $263 Million in a…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Starbucks is about to report earnings. Here’s what to expect
Douglas L. Grider
January 28, 2026
The ‘20% rule’ behind Giorgos Tsetis’ blueprint for a new kind of family office
Douglas L. Grider
August 13, 2026
FDA fast-tracks psychedelic drug research following Trump executive order
Douglas L. Grider
April 24, 2026
